Search - tctmd.com

Displaying 1 - 2 of 2

Sort: Relevancy | Date

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Structural Heart Disease: What’s new in 2018?

Presentation CIT 2018

Structural Heart Disease: What’s new in 2018?

Presenter: David Hildick-Smith

March 23, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.